Accéder au contenu
Merck

Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.

The Journal of clinical investigation (2020-03-24)
Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai, Sharon R Stevens, Qianghu Wang, Daniel Zamler, Takashi Shingu, Liang Yuan, Chythra R Chandregowda, Yunfei Wang, Visweswaran Ravikumar, Arvind Uk Rao, Feng Zhou, Hongwu Zheng, Matthew N Rasband, Yiwen Chen, Fei Lan, Amy B Heimberger, Benjamin M Segal, Jian Hu
RÉSUMÉ

Lipid-rich myelin forms electrically insulating, axon-wrapping multilayers that are essential for neural function, and mature myelin is traditionally considered metabolically inert. Surprisingly, we discovered that mature myelin lipids undergo rapid turnover, and quaking (Qki) is a major regulator of myelin lipid homeostasis. Oligodendrocyte-specific Qki depletion, without affecting oligodendrocyte survival, resulted in rapid demyelination, within 1 week, and gradually neurological deficits in adult mice. Myelin lipids, especially the monounsaturated fatty acids and very-long-chain fatty acids, were dramatically reduced by Qki depletion, whereas the major myelin proteins remained intact, and the demyelinating phenotypes of Qki-depleted mice were alleviated by a high-fat diet. Mechanistically, Qki serves as a coactivator of the PPARβ-RXRα complex, which controls the transcription of lipid-metabolism genes, particularly those involved in fatty acid desaturation and elongation. Treatment of Qki-depleted mice with PPARβ/RXR agonists significantly alleviated neurological disability and extended survival durations. Furthermore, a subset of lesions from patients with primary progressive multiple sclerosis were characterized by preferential reductions in myelin lipid contents, activities of various lipid metabolism pathways, and expression level of QKI-5 in human oligodendrocytes. Together, our results demonstrate that continuous lipid synthesis is indispensable for mature myelin maintenance and highlight an underappreciated role of lipid metabolism in demyelinating diseases.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-Olig-2, Chemicon®, from rabbit
Sigma-Aldrich
Anticorps anti-Olig2, clone 211F1.1, clone 211F1.1, from mouse
Sigma-Aldrich
Anticorps anti-Aspa/Nur7, from rabbit, purified by affinity chromatography
Sigma-Aldrich
Anticorps anti-protéine basique de la myéline, serum, Chemicon®
Sigma-Aldrich
Bexarotene, ≥98% (HPLC)
Sigma-Aldrich
Monoclonal Anti-Qki (Pan) antibody produced in mouse, clone S147-6, purified immunoglobulin